Quantcast

Health Care Sector Update for 06/08/2018: ALNY, NVS, MYOV, BTX, TROV


Shutterstock photo

Top Health Care stocks:

JNJ: -0.03%

PFE: +0.1%

ABT: flat

MRK: -0.1%

AMGN: flat

Health care shares were lower ahead of the bell on Friday.

Expected movers:

- Alnylam Pharmaceuticals ( ALNY ): reported positive results from its phase 1/2 clinical trial of its drug lumasiran to treat primary hyperoxaluria type 1

- Novartis AG ( NVS ): reported data from a phase 3 trial showed that treatment with Lutathera provided significantly longer time to deterioration of quality of life for patients with progressive midgut Neuroendocrine tumors

- Myovant Sciences ( MYOV ): reports wider Q4 loss from prior year, misses estimates

Other news:

- BioTime ( BTX ): to distribute some or all of its equity stake in a subsidiary, AgeX Therapeutics, Inc., to the company's shareholders on a pro-rata basis

- TrovaGene ( TROV ): priced an underwritten public offering of 18 million shares and warrants at $1 per share

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.



This article appears in: Investing , US Markets
Referenced Symbols: ALNY , NVS , MYOV , BTX , TROV


More from MT Newswires

Subscribe






MT Newswires
Contributor:

MT Newswires

Market News, Commodities








Research Brokers before you trade

Want to trade FX?